GlaxoSmithKline plc Share Price London S.E.
Stocks
Pharmaceuticals
OTC Markets Traded|
End-of-day quote
London S.E.
|
||
| - GBX | - |
|
| 01:57pm | The Rally Is Getting Lonely |  |
| 08:42am | GSK plc : Berenberg remains its Buy rating | ZD |
| Market Cap | 70.74B 93.43B 83.48B 77.88B 133B 9,038B 134B 936B 366B 4,596B 351B 343B 14,776B | P/E 2026 * |
13.7x | P/E 2027 * | 11.3x |
|---|---|---|---|---|---|
| Enterprise Value | 91.95B 121B 109B 101B 173B 11,748B 174B 1,217B 475B 5,975B 456B 446B 19,207B | EV / Sales 2026 * |
2.71x | EV / Sales 2027 * | 2.51x |
| Free-Float |
92.75% | Yield 2026 * |
3.93% | Yield 2027 * | 4.24% |
Last Transcript: GlaxoSmithKline plc
| Manager | Title | Age | Since |
|---|---|---|---|
Luke Miels
CEO | Chief Executive Officer | 52 | 31/12/2025 |
Julie Brown
DFI | Director of Finance/CFO | 64 | 30/04/2023 |
James Ford
CMP | Compliance Officer | - | 31/07/2018 |
| Director | Title | Age | Since |
|---|---|---|---|
Luke Miels
BRD | Director/Board Member | 52 | 05/05/2026 |
Hal Barron
BRD | Director/Board Member | 64 | 31/12/2017 |
Jonathan Symonds
CHM | Chairman | 67 | 31/08/2019 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +3.34% | +3.28% | +41.65% | +109.01% | 1,032B | |
| +2.00% | -1.76% | +37.69% | +64.05% | 614B | |
| +2.23% | +4.38% | +17.27% | +83.12% | 471B | |
| +0.58% | -1.85% | +62.80% | +36.48% | 350B | |
| +2.92% | +3.12% | +24.78% | +43.51% | 337B | |
| +2.42% | +0.05% | +14.13% | +36.19% | 268B | |
| +1.86% | -0.81% | -4.69% | +12.20% | 246B | |
| +2.47% | -1.97% | +39.81% | +52.17% | 218B | |
| +2.28% | -1.14% | +26.18% | +96.32% | 179B | |
| Average | +2.00% | -3.39% | +28.85% | +59.23% | 412.76B | |
| Weighted average by Cap. | +2.27% | -3.18% | +32.46% | +69.90% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 33.93B 44.8B 40.03B 37.35B 63.89B 4,334B 64.37B 449B 175B 2,204B 168B 165B 7,086B | 35.53B 46.93B 41.93B 39.12B 66.92B 4,539B 67.42B 470B 184B 2,309B 176B 172B 7,421B |
| Net income | 5.19B 6.85B 6.12B 5.71B 9.77B 663B 9.85B 68.66B 26.82B 337B 25.73B 25.18B 1,084B | 6.21B 8.2B 7.33B 6.84B 11.7B 794B 11.79B 82.19B 32.11B 404B 30.8B 30.13B 1,298B |
| Net Debt | 21.21B 28.01B 25.03B 23.35B 39.95B 2,710B 40.25B 281B 110B 1,378B 105B 103B 4,430B | 18.49B 24.42B 21.82B 20.36B 34.83B 2,363B 35.09B 245B 95.59B 1,202B 91.69B 89.71B 3,863B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Select your edition
All financial news and data tailored to specific country editions
